|
Dec 31
|
Brii Bio Announces Signing of Asset Purchase Agreements Acquiring BRII-179 IP Rights and Completed Patient Enrollment for ENRICH Study
|
|
Jun 7
|
Brii Bio Presents New Data from Its Ongoing Phase 2 Chronic Hepatitis B Trials at EASL™ Congress 2024
|
|
Aug 22
|
Brii Biosciences Provides Corporate Updates and Reports 2023 Interim Results
|